|
|
Volumn 73, Issue 3, 2001, Pages 369-377
|
|
Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: Results obtained by the kyushu-yamaguchi children's cancer study group
|
|
Author keywords
Acute lymphoblastic leukemia; Chemotherapy; Child; Growth impairment; Late effect
|
|
Indexed keywords
AL851 PROTOCOL;
ALHR88 PROTOCOL;
ANTINEOPLASTIC AGENT;
ASPARAGINASE;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DAUNORUBICIN;
METHOTREXATE;
MSK NY II PROTOCOL, MODIFIED;
MSK-NY-II PROTOCOL, MODIFIED;
PREDNISOLONE;
VINCRISTINE;
ACUTE LYMPHOCYTIC LEUKEMIA;
ADOLESCENT;
BODY HEIGHT;
BODY WEIGHT;
CHEMICALLY INDUCED DISORDER;
CHILD;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
DISEASE FREE SURVIVAL;
FEMALE;
GROWTH DISORDER;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
INFANT;
JAPAN;
MALE;
MORTALITY;
MULTICENTER STUDY;
MULTIMODALITY CANCER THERAPY;
MYELODYSPLASTIC SYNDROME;
PRESCHOOL CHILD;
REMISSION;
RETROSPECTIVE STUDY;
REVIEW;
SALVAGE THERAPY;
SECOND CANCER;
SKULL IRRADIATION;
SURVIVAL RATE;
SURVIVOR;
TREATMENT OUTCOME;
ADOLESCENT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ASPARAGINASE;
BODY HEIGHT;
BODY WEIGHT;
CHILD;
CHILD, PRESCHOOL;
CLINICAL TRIALS;
COMBINED MODALITY THERAPY;
CRANIAL IRRADIATION;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DAUNORUBICIN;
DISEASE-FREE SURVIVAL;
FEMALE;
GROWTH DISORDERS;
HEART FAILURE, CONGESTIVE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
INFANT;
JAPAN;
LEUKEMIA, LYMPHOCYTIC, ACUTE, L1;
MALE;
METHOTREXATE;
MYELODYSPLASTIC SYNDROMES;
NEOPLASMS, SECOND PRIMARY;
PREDNISOLONE;
REMISSION INDUCTION;
RETROSPECTIVE STUDIES;
SALVAGE THERAPY;
SURVIVAL RATE;
SURVIVORS;
TREATMENT OUTCOME;
VINCRISTINE;
|
|
EID: 0035320652
PISSN: 09255710
EISSN: None
Source Type: Journal
DOI: 10.1007/BF02981964 Document Type: Article |
|
Times cited : (19)
|
|
References (3)
|
